
Eiko Lifesciences Ltd is Rated Sell
2026-05-04 10:10:03Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Eiko Lifesciences Ltd is Rated Sell
2026-04-21 10:10:03Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook.
Read full news article
Eiko Lifesciences Ltd is Rated Sell
2026-04-10 10:10:03Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Eiko Lifesciences Ltd Falls to 52-Week Low of Rs 45.9 as Sell-Off Deepens
2026-03-30 14:27:25A 30.3% decline from its 52-week high of Rs 65.9 has dragged Eiko Lifesciences Ltd to a fresh 52-week low of Rs 45.9 on 30 Mar 2026, marking a notable downturn despite recent positive earnings trends.
Read full news article
Eiko Lifesciences Ltd is Rated Sell
2026-03-30 10:10:02Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news article
Eiko Lifesciences Ltd is Rated Sell
2026-03-16 10:10:02Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with the most up-to-date insight into the company's performance and outlook.
Read full news article
Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO
2026-03-04 10:10:02Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Eiko Lifesciences Ltd is Rated Sell
2026-02-16 10:10:04Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleNon Applicability Of Annual Disclosure As Per SEBI Circular - Fund Raising By Issuance Of Debt Securities By Large Corporates.
09-Apr-2026 | Source : BSEIn view of SEBI circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November 2018 and amendments thereto (the said Circular) we wish to inform you that as on 31st March 2026 Eiko Lifesciences Ltd. is not a Large Corporate in terms of the criteria specified under the said SEBI Circular. In view of this the framework for fund raising by issuance of Debt Securities by Large Corporate is not applicable to Eiko Lifesciences Ltd. and the requirement of filing the initial disclosure and annual disclosure does not arise.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Apr-2026 | Source : BSECertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter and year ended on 31st March 2026 received from M/s. Bigshare Services Pvt. Ltd. Registrar and Share Transfer Agent of the Company.
Closure of Trading Window
25-Mar-2026 | Source : BSEPursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 as amended and as per Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders (Code) the trading window for dealing in the securities of the Company shall remain closed for designated persons and their immediate relatives from Wednesday 01st April 2026 till 48 hours after the date of Board Meeting wherein inter-alia the approval of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2026 would be considered by the Board.
Corporate Actions
No Upcoming Board Meetings
Eiko Lifesciences Ltd has declared 2% dividend, ex-date: 20 Sep 17
No Splits history available
No Bonus history available
Eiko Lifesciences Ltd has announced 2:3 rights issue, ex-date: 07 Jul 23






